Cuu Long Pharmaceutical JSC (HOSE:DCL)

Vietnam · Delayed Price · Currency is VND

38,300

+100 (0.26%)

At close: Jul 2, 2026

65.44% (1Y)

Market Cap	2.80T +27.4%
Revenue (ttm)	1.31T -4.6%
Net Income	-7.32B
EPS	-100.44
Shares Out	73.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	404,914
Open	38,000
Previous Close	38,200
Day's Range	38,000 - 38,400
52-Week Range	20,850 - 62,800
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antihistamine, musculoskeletal, dermatology, analgesics and antipyretics, antibiotics, analgesics and anti-inflammatories, respiratory, gastrointestinal, cardiovascular, vitamins and minerals, and nervous medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, pharmac... [Read more]

Industry Pharmaceutical Preparations

Founded 1976

Employees 891

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol DCL

Full Company Profile

Financial Performance

In 2025, HOSE:DCL's revenue was 1.32 trillion, an increase of 1.13% compared to the previous year's 1.31 trillion. Earnings were 19.52 billion, a decrease of -62.16%.

Financial Statements